Neuralink human trial
Neuralink, Elon Musk’s brain-implant startup said it has received approval to begin recruitment for the first human trial for its brain implant for paralysis patients.
The trial, which is slated to take an initial six years, is intended to test tech designed by the company. People being targeted are quadriplegic patients with vertical spinal cord injury or ALS who are over the age of 22.
Neuralink has previously come under scrutiny over the company’s treatment of monkeys in testing while also being under investigation for illegally transporting pathogen-laced devices removed from the monkeys by the Department of Transportation.
In May, the company said it had received clearance from the FDA for its first-in-human clinical trial.
The company has said the initial goal of the study is to enable people to control a computer cursor or keyboard using their thoughts alone.
Walk through almost any home with more than one floor and you will pass through…
The world today moves at the speed of a swipe. From morning notifications to late-night…
In the middle of modern cities filled with glass, concrete, and constant motion, something quietly…
Government policies are not just distant decisions made in offices far away. They shape the…
Improving your lifestyle does not always require big changes. In fact, it’s the small, consistent…
Artificial Intelligence is no longer a futuristic idea found only in science fiction. In 2025,…